- /
- Supported exchanges
- / US
- / ICCM.NASDAQ
Icecure Medical (ICCM NASDAQ) stock market data APIs
Icecure Medical Financial Data Overview
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Icecure Medical data using free add-ons & libraries
Get Icecure Medical Fundamental Data
Icecure Medical Fundamental data includes:
- Net Revenue: 3 947 K
- EBITDA: -16 439 000
- Earnings Per Share: -6
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: -1.37
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Icecure Medical News
New
IceCure Secures China NMPA Approval for ProSense Cryoablation System
IceCure Medical ICCM recently secured regulatory approval from China's National Medical Products Administration ("NMPA") for its ProSense cryoablation system and associated cryoprobes. The clearance m...
IceCure Medical Ltd Q2 2026 Earnings Call Summary
IceCure Medical Ltd Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you ...
Danaher (DHR) Q2 Earnings and Revenues Top Estimates
Danaher (DHR) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.84 per share. This compares to earnings of $1.8 per share a year ago. These figures are ad...
IceCure Highlights Expanding Adoption Of ProSense Cryoablation In Brazil
(RTTNews) - IceCure Medical Ltd. (ICCM) developer of minimally-invasive cryoablation technology, announced growing commercial adoption of its ProSense system in Brazil following FDA marketing authoriz...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.